title: Coinfection with epstein barr virus in north Indian patients with HIV/AIDS.
abstract: Acquired immunodeficiency syndrome (AIDS) has emerged as a serious health problem in India. Although tuberculosis appears to be the commonest opportunistic infection, studies pertaining to opportunistic viruses are scant In the present study co infection with EBV was evaluated in patients with AIDS using a highly sensitive polymerase chain reaction besides anti Zebra antibody assays for diagnosis of an active EBV infection in 37 patients of full-blown AIDS and 32 healthy seropositives. Thirty healthy laboratory workers were used as controls. Out of 37 patients with AIDS, 12 were positive for anti Zebra antibodies and 23 were positive for EBV by the PCR reaction. Out of the 32 seropositives, 3 were positive for anti Zebra antibodies and 4 were positive by PCR assay. The difference between seropositives and AIDS was significant (p < .05). None of the controls were positive for an active EBV infection. It is concluded that active EBV infection is an important co infection in patients with AIDS and may contribute significantly to morbidity and mortality in these patients.
authors.affiliation: Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh.
authors.forename: S
authors.initials: S
authors.lastname: Mujtaba
authors.forename: S
authors.initials: S
authors.lastname: Varma
authors.forename: S
authors.initials: S
authors.lastname: Sehgal
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D004268:DNA-Binding Proteins / Q000276:immunology; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology*; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000453:epidemiology* / Q000821:virology; D006679:HIV Seropositivity / Q000150:complications / Q000453:epidemiology / Q000821:virology; D015497:HIV-1 / Q000302:isolation & purification; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D015994:Incidence; D007194:India / Q000453:epidemiology; D008297:Male; D016133:Polymerase Chain Reaction / Q000379:methods; D015534:Trans-Activators / Q000276:immunology; D014764:Viral Proteins / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; C063676:BZLF1 protein, Herpesvirus 4, Human; D004268:DNA-Binding Proteins; D015534:Trans-Activators; D014764:Viral Proteins